Collegium Pharmaceutical, Inc. (COLL) Revenue History
Collegium Pharmaceutical, Inc. (COLL) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $1.71M |
| 2017-12-31 | $28.48M |
| 2018-12-31 | $280.41M |
| 2019-12-31 | $296.70M |
| 2020-12-31 | $310.02M |
| 2021-12-31 | $276.87M |
| 2022-12-31 | $463.93M |
| 2023-12-31 | $566.77M |
| 2024-12-31 | $631.45M |
| 2025-12-31 | $780.57M |
How COLL compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| MYGN | Myriad Genetics Inc. | $824.50M |
| USPH | U.S. Physical Therapy Inc. | $780.99M |
| EBS | Emergent BioSolutions Inc. | $742.90M |
| NEO | NeoGenomics Inc. | $727.33M |
| AMPH | Amphastar Pharmaceuticals Inc. | $719.89M |
These are five companies in the same sector as COLL with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Collegium Pharmaceutical, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("COLL", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | COLL | $27.11 | -1.56% | 0.70M |
| 3 | ||||
| 4 | ||||
| 5 |